These range from FDA-approved medications, such as GLP-1 receptor agonists (Wegovy, Zepbound) for weight loss, to unregulated compounds with minimal or no human safety data
The peptides under consideration this week are: BPC-157, proposed for treating ulcerative colitis KPV for wound healing and inflammatory conditions TB-500 for wound healing MOTS-c for obesity and osteoporosis Emideltide for opioid withdrawal, chronic insomnia and narcolepsy Semax for certain neurological disorders Epitalon for insomnia The FDA advisory committee will be determining whether or not it will allow access to these substances through legitimate state-licensed compounding pharmacies, said Scott Brunner, chief executive officer of the Alliance for Pharmacy Compounding, who sent a public letter to the committee in support of adding peptides to the list
A 2018 study in Life Sciences demonstrated that BPC-157 accelerated muscle healing in rats by reducing inflammation and promoting satellite cell activation, which is essential for muscle regeneration (Seiwerth et al., 2018)
We are a leading primary care practice and weight loss clinic in Canton, MI
Current Pharmaceutical Design , 2020 Whether youre struggling with inflammatory bowel conditions, damage from medications, or chronic gut dysfunction, BPC-157 may offer a new path to targeted digestive healing especially when other interventions have failed
If non-drowsy antihistamines are not effective enough, taking diphenhydramine 25mg about 30 to 60 minutes before your injection, preferably in the evening, provides stronger histamine blockade
